Catalyst Pharmaceuticals announces FIRDAPSE launch in Japan by DyDo Pharma for treating Lambert-Eaton myasthenic syndrome. Quiver AI Summary. Catalyst Pharmaceuticals, Inc. announced that its sub ...

A medical expert discusses how disparities in health care access affect the management and outcomes of Lambert-Eaton myasthenic syndrome (LEMS) in patients with small cell lung cancer, how health ...

A medical expert discusses how Lambert-Eaton myasthenic syndrome is closely linked to small cell lung cancer, the challenges in differentiating it from other neuromuscular disorders like ...

Amifampridine tablets are indicated for the treatment of Lambert-Eaton myasthenic syndrome in adults and pediatric patients 6 years of age and older. Sandra Levy. 3/20/2025.